Trial Profile
Biodistribution, Imaging Properties, and Radiation Dosimetry of [18F]-GP1 Positron Emission Tomography (PET) Tracer in Vascular Disease Imaging
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 30 Apr 2019
Price :
$35
*
At a glance
- Drugs 18F GP1 (Primary)
- Indications Abdominal aortic aneurysm; Deep vein thrombosis
- Focus Diagnostic use; First in man
- 27 Mar 2019 According to a Life Molecular Imaging, Piramal imaging changed its name to Life Molecular Imaging.
- 08 May 2017 Status changed from recruiting to discontinued.
- 26 Oct 2016 Planned End Date changed from 1 Jul 2016 to 1 Dec 2016.